UK markets closed

Autolus Therapeutics plc (AUTL)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
5.52-0.41 (-6.91%)
At close: 4:00PM EDT
Currency in USD

Valuation measures

Market cap (intra-day) 5389.62M
Enterprise value 3-146.18k
Trailing P/E N/A
Forward P/E 1-2.88
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)361.27
Price/book (mrq)0.93
Enterprise value/revenue 3-0.14
Enterprise value/EBITDA 70.00

Trading information

Stock price history

Beta (5Y monthly) 1.69
52-week change 3-61.13%
S&P500 52-week change 336.19%
52-week high 316.78
52-week low 34.60
50-day moving average 36.74
200-day moving average 36.72

Share statistics

Avg vol (3-month) 31.83M
Avg vol (10-day) 31.26M
Shares outstanding 570.58M
Implied shares outstanding 6N/A
Float 33.9M
% held by insiders 126.09%
% held by institutions 136.10%
Shares short (29 Jun 2021) 42M
Short ratio (29 Jun 2021) 40.9
Short % of float (29 Jun 2021) 4N/A
Short % of shares outstanding (29 Jun 2021) 42.84%
Shares short (prior month 27 May 2021) 42.23M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)30 Dec 2018


Profit margin 0.00%
Operating margin (ttm)-6,570.75%

Management effectiveness

Return on assets (ttm)-22.27%
Return on equity (ttm)-29.62%

Income statement

Revenue (ttm)1.08M
Revenue per share (ttm)0.03
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)-133.17M
EBITDA -68.94M
Net income avi to common (ttm)-53.28M
Diluted EPS (ttm)-1.40
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)217.45M
Total cash per share (mrq)5.52
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)11.05
Book value per share (mrq)5.91

Cash flow statement

Operating cash flow (ttm)N/A
Levered free cash flow (ttm)N/A